Iron Triangle Partners LP Purchases 2,999 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Iron Triangle Partners LP grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.2% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 75,000 shares of the medical equipment provider's stock after purchasing an additional 2,999 shares during the period. Intuitive Surgical comprises approximately 4.3% of Iron Triangle Partners LP's portfolio, making the stock its 11th biggest position. Iron Triangle Partners LP's holdings in Intuitive Surgical were worth $39,147,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Atala Financial Inc bought a new stake in Intuitive Surgical during the 4th quarter worth approximately $25,000. Berbice Capital Management LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $26,000. Parvin Asset Management LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. Finally, Hurley Capital LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. 83.64% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the company. Wells Fargo & Company boosted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. UBS Group boosted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research note on Monday, January 27th. Erste Group Bank downgraded Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 17th. Raymond James boosted their target price on Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Finally, Truist Financial dropped their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a research note on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and an average price target of $598.95.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Jami K. Nachtsheim sold 2,400 shares of the company's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total value of $1,248,000.00. Following the transaction, the director now owns 6,371 shares of the company's stock, valued at approximately $3,312,920. This represents a 27.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 2,401 shares of the company's stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares in the company, valued at approximately $205,093. The trade was a 87.18% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 32,636 shares of company stock valued at $16,829,815 in the last 90 days. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

ISRG stock traded down $2.10 during midday trading on Wednesday, reaching $561.85. 159,820 shares of the company's stock traded hands, compared to its average volume of 1,629,377. The company has a 50-day moving average price of $501.31 and a two-hundred day moving average price of $535.58. Intuitive Surgical, Inc. has a 52 week low of $379.67 and a 52 week high of $616.00. The firm has a market capitalization of $201.38 billion, a PE ratio of 87.49, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the previous year, the firm posted $1.50 EPS. As a group, analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.